2022/04/21 ALA-1000 Received notice of patent allowance from Intellectual Property Office of Singapore (IPOS), Application No. 11201901294Q. Post author:alarpharm Post published:21 . 4 . 2022 Post category:Media releases You Might Also Like 2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S) 23 . 8 . 2023 2022/05/06 ALA-1000 Received notice of patent allowance from Intellectual Property Office of India , Application No. 201947006642 9 . 5 . 2022 2022/05/12 ALA-1000 Received notice of patent allowance from Director de Invenciones y Nuevas Tecnologías INDECOPI , Application No. 000487-2019/DIN. 13 . 5 . 2022 2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023 2023/08/07 ALA-3000 has received an Resolution of acceptance to registration from Instituto Nacional de Propiedad Industrial (INAPI)-Chile after the examination. (Patent Application No. 202101803) 10 . 8 . 2023
2023/08/21 ALA-3000 has received the Notice of Eligibility of Grant from Intellectual Property Office of Singapore (IPOS) after the examination.(Patent Application No. 11202104792S) 23 . 8 . 2023
2022/05/06 ALA-1000 Received notice of patent allowance from Intellectual Property Office of India , Application No. 201947006642 9 . 5 . 2022
2022/05/12 ALA-1000 Received notice of patent allowance from Director de Invenciones y Nuevas Tecnologías INDECOPI , Application No. 000487-2019/DIN. 13 . 5 . 2022
2023/06/29 ALA-1000 Received the patent, SUSTAINED-RELEASE BUPRENORPHINE FORMULATIONS, from Intellectual Property Corporation of Malaysia (MyIPO) , NO : MY-196269-A 30 . 6 . 2023
2023/08/07 ALA-3000 has received an Resolution of acceptance to registration from Instituto Nacional de Propiedad Industrial (INAPI)-Chile after the examination. (Patent Application No. 202101803) 10 . 8 . 2023
